webinar register page

Webinar banner
Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis
This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway Analysis (IPA) can be used discover new biomarkers, validate (or study) drug targets and identify novel mechanism of action with user and/or public Immuno-Oncology studies from resources like GEO, SRA, TCGA and more.
Attendees will learn how to
• Investigate expression of a gene/biomarker/drug target across different treatments and diseases
• Derive a biomarker/gene signature from specific condition (example non-responders of a drug, a specific disease/disease subtype and more)
• Correlate expression of multiple genes and biomarkers
• Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels


Webinar logo
* Required information

DISCLAIMER: QIAGEN may use your personal information for the purpose of participation in the webinar, informing you about future events and for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting, marketing calls and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation. For further details please refer to our Privacy Policy.